Subclinical cardiovascular target organ damage manifestations of ankylosing spondylitis in young adult patients
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Although it is known that ankylosing spondylitis (AS) is associated with cardiovascular complications, the extent of these complications has not been clearly demonstrated in young adult patients. We have therefore investigated myocardial diastolic functions, carotid intima-media thickness (CIMT), and aortic elastic properties of young adult patients diagnosed with AS.
Sixty-six AS patients and 21 age/gender-matched healthy subjects were enrolled in the study. Spectral and tissue Doppler echocardiography, CIMT, aortic strain and distensibility, and serum B-type natriuretic peptide values were compared with disease activity indexes of AS, including the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the role of other variables, such as anti-tumor necrosis factor-alpha (anti-TNF-α) treatment, lipid parameters, erythrocyte sedimentation rate, and C-reactive protein.
Both mitral early diastolic flow speed (mE) and late diastolic flow speed (mA) scores were lower among patients than among the control subjects (p = 0.015 and p = 0.035, respectively). The Em ratio of the patients was remarkably lower than that of the control subjects (p = 0.044). BASDAI scores of >4 were used to identify patients with more active disease. The mA and mE/mA ratios were significantly different between patients with a BASDAI score of >4 and those with a BASDAI score of <4 (p = 0.026 and p = 0.021, respectively). While aortic elasticity were not significantly different between the groups, AS patients treated with anti-TNF-α had significantly improved aortic strain and distensibility values (p = 0.022 and p = 0.014, respectively) compared to those treated with non-steroidal anti-inflammatory drugs (NSAIDs).
Myocardial diastolic functions were significantly deteriorated in the AS patients, and disease activity and myocardial diastolic functions were associated. An interesting finding was that patients receiving anti-TNF-α had better aortic elasticity than those treated with NSAIDs.
- Momeni M, Taylor N, Tehrani M. Cardiopulmonary manifestations of ankylosing spondylitis. Int J Rheumatol. 2011;2011:728471.
- Gould BA, Turner J, Keeling DH, Hickling P, Marshall AJ. Myocardial dysfunction in ankylosing spondylitis. Ann Rheum Dis. 1992;51:227–32. CrossRef
- O’Neill TW, Bresnihan B. The heart in ankylosing spondylitis. Ann Rheum Dis. 1992;51:705–6. CrossRef
- Yildirir A, Aksoyek S, Calguneri M, Oto A, Kes S. Echocardiographic evidence of cardiac involvement in ankylosing spondylitis. Clin Rheumatol. 2002;21:129–34. CrossRef
- Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361–8. CrossRef
- Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21:2286–91.
- Lacombe F, Dart A, Dewar E, Jennings G, Cameron J, Laufer E. Arterial elastic properties in man: a comparison of echo-Doppler indices of aortic stiffness. Eur Heart J. 1992;13:1040–5.
- Stefanadis C, Wooley CF, Bush CA, Kolibash AJ, Boudoulas H. Aortic distensibility in post-stenotic aortic dilatation: the effect of co-existing coronary artery disease. J Cardiol. 1988;18:189–95.
- Brunner F, Kunz A, Weber U, Kissling R. Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population? Clin Rheumatol. 2005;25:24–9. CrossRef
- Davutoglu V, Yildirim C, Kucukaslan H, Yuce M, Sari I, Tarakcioglu M, Akcay M, Cakici M, Ceylan N, Al B. Prognostic value of pleural effusion, CA-125 and NT-proBNP in patients with acute decompensated heart failure. Kardiol Pol. 2010;68:771–8.
- Davutoglu V, Celik A, Aksoy M, Sezen Y, Soydinc S, Gunay N. Plasma NT-proBNP is a potential marker of disease severity and correlates with symptoms in patients with chronic rheumatic valve disease. Eur J Heart Fail. 2005;7:532–6. CrossRef
- Grewal J, McKelvie R, Lonn E, Tait P, Carlsson J, Gianni M, Jarnert C, Persson H. BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail. 2008;10:252–9. CrossRef
- Sakuragi S, Iwasaki J, Tokunaga N, Hiramatsu S, Ohe T. Aortic stiffness is an independent predictor of left ventricular function in patients with coronary heart disease. Cardiology. 2005;103:107–12. CrossRef
- Verbeke F, Van Biesen W, Honkanen E, Wikström B, Jensen PB, Krzesinski JM, Rasmussen M, Vanholder R, CORD Study Investigators. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol. 2011;6:153–9. CrossRef
- Sweitzer NK, Shenoy M, Stein JH, Keles S, Palta M, LeCaire T, Mitchell GF. Increases in central aortic impedance precede alterations in arterial stiffness measures in type 1 diabetes. Diabetes Care. 2007;30:2886–91. CrossRef
- Eren M, Gorgulu S, Uslu N, Celik S, Dagdeviren B, Tezel T. Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both. Heart. 2004;90:37–43. CrossRef
- Gasecki D, Rojek A, Kwarciany M, Kubach M, Boutouyrie P, Nyka W, Laurent S, Narkiewicz K. Aortic stiffness predicts functional outcome in patients after ischemic stroke. Stroke. 2012;43:543–4. CrossRef
- Roldan CA, Joson J, Qualls CR, Sharrar J, Sibbitt WL Jr. Premature aortic stiffness in systemic lupus erythematosus by transesophageal echocardiography. Lupus. 2010;19:1599–605. CrossRef
- Roldan CA, Chavez J, Wiest PW, Qualls CR, Crawford MH. Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol. 1998;32:1397–404. CrossRef
- Sucu MM, Davutoglu V, Akcay M, Yiğiter R, Al B. Aortic elastic properties of patients with neurocardiogenic syncope. Pacing Clin Electrophysiol. 2009;32:1417–21. CrossRef
- Pannier B, London GM. Effects of aortic stiffness abnormalities on the heart. Semin Dial. 2011;24:282–5. CrossRef
- Bodnár N, Kerekes G, Seres I, Paragh G, Kappelmayer J, Némethné ZG, Szegedi G, Shoenfeld Y, Sipka S, Soltész P, Szekanecz Z, Szántó S. Assessment of subclinical vascular disease associated with ankylosing spondylitis. J Rheumatol. 2011;38:723–9. CrossRef
- Azevedo VF, Pecoits-Filho R. Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis. Rheumatol Int. 2010;30:1411–6. CrossRef
- Mathieu S, Joly H, Baron G, Tournadre A, Dubost JJ, Ristori JM, Lusson JR, Soubrier M. Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease. Rheumatology (Oxford). 2008;47:1203–7. CrossRef
- Erre GL, Sanna P, Zinellu A, Ponchietti A, Fenu P, Sotgia S, Carru C, Ganau A, Passiu G. Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study. Clin Rheumatol. 2011;30:21–7. CrossRef
- Otani H. The role of nitric oxide in myocardial repair and remodeling. Antioxid Redox Signal. 2009;11:1913–28. CrossRef
- Wofford J, Kahl F, Howard G, McKinney W, Toole J, Crouse JI. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb. 1991;11:1786–94. CrossRef
- Mathıeu S, Gossec L, Dougados M, Soubrıer M. Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res. 2011;63:557–63. CrossRef
- Caliskan M, Erdogan D, Gullu H, Yilmaz S, Gursoy Y, Yildirir A, Yucel E, Muderrisoglu H. Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis. Atherosclerosis. 2008;196:306–12. CrossRef
- Sari I, Okan T, Akar S, Cece H, Altay C, Secil M, Birlik M, Onen F, Akkoc N. Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford). 2006;45:283–6. CrossRef
- Malesci D, Niglio A, Mennillo GA, Buono R, Valentini G, La Montagna G. High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26:710–4. CrossRef
- Choe JY, Lee MY, Rheem I, Rhee MY, Park SH, Kim SK. No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls. Joint Bone Spine. 2008;75:548–53. CrossRef
- Subclinical cardiovascular target organ damage manifestations of ankylosing spondylitis in young adult patients
Volume 23, Issue 6 , pp 1063-1068
- Cover Date
- Print ISSN
- Online ISSN
- Springer Japan
- Additional Links
- Ankylosing spondylitis
- Aortic elasticity
- Myocardial diastolic dysfunction
- Carotid intima-media thickness
- Industry Sectors
- Author Affiliations
- 1. Department of Cardiology, School of Medicine, Gaziantep University, 27310, Gaziantep, Turkey
- 2. Department of Rheumatology, School of Medicine, Gaziantep University, Gaziantep, Turkey